Showing results (31-40 of 130) with videos related to
Sort By:
Pageof 13
Annals of Hematology|March 28, 2022
Low-risk polycythemia vera and essential thrombocythemia: management considerations and future directionsHannah Goulart, John Mascarenhas, Douglas TremblayClinical Lymphoma, Myeloma & Leukemia|July 14, 2016
Discontinuing Tyrosine Kinase Inhibitor Therapy in Chronic Myelogenous Leukemia: Current Understanding and Future DirectionsSheena Bhalla, Douglas Tremblay, John MascarenhasCancers|January 8, 2023
Splanchnic Vein Thrombosis in Myeloproliferative Neoplasms: Treatment Considerations and Unmet NeedsAngela Liu, Leonard Naymagon, Douglas TremblayHematology/Oncology Clinics of North America|March 1, 2021
Overview of Myeloproliferative Neoplasms: History, Pathogenesis, Diagnostic Criteria, and ComplicationsDouglas Tremblay, Abdulraheem Yacoub, Ronald HoffmanLeukemia & Lymphoma|November 30, 2023
Understanding triple negative myeloproliferative neoplasms: pathogenesis, clinical features, and managementSerena Tharakan, John Mascarenhas, Douglas TremblayDrugs|August 10, 2017
Pharmacotherapy of MyelofibrosisDouglas Tremblay, Bridget Marcellino, John MascarenhasHaematologica|April 23, 2026
Effect of intravenous immunoglobulin on infections in multiple myeloma patients receiving daratumumabGuido Lancman, Dahniel Sastow, Minira Aslanova, et al.European Journal of Haematology|January 29, 2020
Reevaluating the role of ferritin in the diagnosis of adult secondary hemophagocytic lymphohistiocytosisLeonard Naymagon, Douglas Tremblay, John MascarenhasClinical Lymphoma, Myeloma & Leukemia|September 18, 2022
Thrombocytopenia in Patients With Myelofibrosis: A Practical Management GuideDouglas Tremblay, Ian Baine, John MascarenhasAging and Disease|July 5, 2021
NRF2 Loss Accentuates Parkinsonian Pathology and Behavioral Dysfunction in Human α-Synuclein Overexpressing MiceAnnadurai Anandhan, Nhat Nguyen, Arjun Syal, et al.Pageof 13